Clinical trial
Safety and Efficacy of Normobaric Facemask Oxygen for Hypocapnia in Aneurysmal Subarachnoid Hemorrhage(FOCAL): A Prospective, Multicenter, Proof-of-concept Pilot Study
NCT07343232 is registered in ClinicalTrials.gov with The Chinese University of Hong Kong, Shenzhen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Normobaric Facemask Oxygen for Hypocapnia in Aneurysmal Subarachnoid Hemorrhage(FOCAL): A Prospective, Multicenter, Proof-of-concept Pilot Study
- Lead sponsor
- The Chinese University of Hong Kong, Shenzhen
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- October 30, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aneurysmal subarachnoid hemorrhage (asah)